ConductScience.org, home

Paper16211237

HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).

Fritz G. Int J Oncol, 2005. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Papers, record 16211237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16211237

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
PubMed
Journal
Int J Oncol
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2006-11-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fritz GGerhard

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
NeoplasmsMajor topic
Cell Adhesion
Cell Death
Cell Proliferation
Humans
Neoplasm Metastasis
Radiation, Ionizing
ras GTPase-Activating Proteins
rho GTP-Binding Proteins

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
42495630RHOA at the intersection of inflammation-driven and sporadic colorectal cancer.Front Immunol2026https://conductscience.org/library/papers/42495630PubMed
39941069Statins as Secondary Preventive Agent to Limit Breast Cancer Metastatic Outgrowth.Int J Mol Sci2025https://conductscience.org/library/papers/39941069PubMed
39000261Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL).Int J Mol Sci2024https://conductscience.org/library/papers/39000261PubMed
38380861Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.Leuk Lymphoma2024https://conductscience.org/library/papers/38380861PubMed
34460030Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study.Breast Cancer Res Treat2021https://conductscience.org/library/papers/34460030PubMed
34303383Statins: a repurposed drug to fight cancer.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34303383PubMed
34001921Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.Sci Rep2021https://conductscience.org/library/papers/34001921PubMed
33755739Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.Naunyn Schmiedebergs Arch Pharmacol2021https://conductscience.org/library/papers/33755739PubMed
32927022Pleiotropic effects of statins: A focus on cancer.Biochim Biophys Acta Mol Basis Dis2020https://conductscience.org/library/papers/32927022PubMed
32046107Inverse Association between Statin Use and Stomach Cancer Incidence in Individuals with Hypercholesterolemia, from the 2002-2015 NHIS-HEALS Data.Int J Environ Res Public Health2020https://conductscience.org/library/papers/32046107PubMed
30895533Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.Breast Cancer Res Treat2019https://conductscience.org/library/papers/30895533PubMed
28796249Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation.Cell Death Dis2017https://conductscience.org/library/papers/28796249PubMed
28481295Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression.Int J Mol Sci2017https://conductscience.org/library/papers/28481295PubMed
28003840Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells.Res Pharm Sci2016https://conductscience.org/library/papers/28003840PubMed
27051303Statin use and mortality of patients with prostate cancer: a meta-analysis.Onco Targets Ther2016https://conductscience.org/library/papers/27051303PubMed
23748751Statins are associated with reduced risk of gastric cancer: a meta-analysis.Eur J Clin Pharmacol2013https://conductscience.org/library/papers/23748751PubMed
22966225The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination.PPAR Res2012https://conductscience.org/library/papers/22966225PubMed
22621227Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.Curr Neurovasc Res2012https://conductscience.org/library/papers/22621227PubMed
19787197Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.Int J Mol Med2009https://conductscience.org/library/papers/19787197PubMed
19520495Molecular mechanisms involved in farnesol-induced apoptosis.Cancer Lett2010https://conductscience.org/library/papers/19520495PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16211237

GET https://conductscience.org/api/papers/v1/16211237/cited_by?page=2